Symphony^TM Biomaker Detection Platform

Bluejay Diagnostics is pleased to present the Symphony biomarker detection platform. The system aims to help improve healthcare outcomes by detecting and preventing cytokine-driven health scares early on.

Symphony is an innovative implementation of the traditionally reliable ELISA methodology combined with modern advances in nanotechnology. The unique design features a combination of microfluidics and interrupted fluid dynamics to offer a fast, simple, safe, and highly sensitive biomarker detection platform.

Dec 14, 2020

BLUEJAY DIAGNOSTICS, INC. ANNOUNCES COLLABORATION AGREEMENT WITH TORAY INDUSTRIES, INC. TO DEVELOP POINT OF CARE TEST FOR COVID-19 PATIENT TRIAGE

Collaboration focused on developing point of care diagnostic test to quantify IL-6 in whole blood. Acton, MA, Dec 8, 2020 – Bluejay Diagnostics, Inc. (Bluejay, Acton, MA) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan) to develop a minimally-invasive, point-of-care test for COVID-19 patients to assess progression of the disease. Symphony™ IL-6 is the first of many products to be developed…